1,078 results on '"Heneghan, Michael A."'
Search Results
2. Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study.
3. Type of calcineurin inhibitor and long-term outcomes following liver transplantation in patients with primary biliary cholangitis – an ELTR study
4. Maternal liver-related symptoms during pregnancy in primary sclerosing cholangitis
5. Critical shortfalls in the management of PBC: Results of a UK-wide, population-based evaluation of care delivery
6. Cyclosporine vs. tacrolimus after liver transplantation for primary sclerosing cholangitis – a propensity score-matched intention-to-treat analysis
7. Patient Priorities in Autoimmune Hepatitis: The Need for Better Treatments, More Education and Challenging Stigma
8. EASL Clinical Practice Guidelines on the management of liver diseases in pregnancy
9. Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report
10. Autoimmune hepatitis and overlap syndromes
11. Exploring Notions of Resilience and Adaptability in the Context of Piloting a Mobile App for Risk Awareness During Covid-19
12. Fertility and Pregnancy
13. Post-Transplant Immunosuppression in Autoimmune Liver Disease
14. Low Baseline but Not Delta Cortisol Relates to 28-Day Transplant-Free Survival in Acute and Acute-on-Chronic Liver Failure
15. Clinical course of inflammatory bowel disease and impact on liver disease outcomes in patients with autoimmune sclerosing cholangitis
16. Invasive coronary angiography as a tool in cardiac evaluation for liver transplant candidates
17. Risk factors and outcomes associated with recurrent autoimmune hepatitis following liver transplantation
18. The impact of advanced patient age in liver transplantation: a European Liver Transplant Registry propensity-score matching study
19. Liver transplantation for HCC: validation of prognostic power of the RETREAT score for recurrence in a UK cohort
20. Quantitative magnetic resonance imaging to aid clinical decision making in autoimmune hepatitis
21. Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group
22. How Does the Aetiology of Primary Liver Disease Affect Anaesthesia for Liver Transplantation
23. Hepatic manifestations of hereditary haemorrhagic telangiectasia
24. WED-137-YI Reviewing the largest experience of liver transplantation for Wilson’s disease in the UK: single centre review of patient and graft outcomes and long term survival
25. THU-111 Second-line treatment in recurrent primary biliary cholangitis after liver transplantation: an international multicentre study
26. LBP-006 Efficacy of elafibranor in primary biliary cholangitis: results from the variable double-blind period of ELATIVE®, a randomised, placebo-controlled phase III trial
27. SAT-057 Poor radiological-histopathological concordance in patients transplanted for hepatocellular carcinoma: a single centre experience
28. SAT-021 Recurrence of autoimmune hepatitis cholestatic variant syndromes after liver transplantation affects graft and patient survival in an international multicentre cohort
29. Non-invasive strategies to predict post-hepatectomy liver failure
30. Type of calcineurin inhibitor and long-term outcomes following liver transplantation in patients with Primary Biliary Cholangitis- an ELTR study
31. An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs
32. Histological activity despite normal ALT and IgG serum levels in patients with autoimmune hepatitis and cirrhosis
33. Towards personalised medicine in autoimmune hepatitis: Measurement of thiopurine metabolites results in higher biochemical response rates
34. A novel microRNA-based prognostic model outperforms standard prognostic models in patients with acetaminophen-induced acute liver failure
35. Interleukin-2 receptor antibody induction with early low dose tacrolimus preserves post-liver transplant renal function in at risk individuals
36. T helper cell immunity in pregnancy and influence on autoimmune disease progression
37. Exploring Notions of Resilience and Adaptability in the Context of Piloting a Mobile App for Risk Awareness During Covid-19
38. A randomized placebo-controlled trial of elafibranor in patients with primary biliary cholangitis and incomplete response to UDCA
39. Safety and efficacy of in vitro fertilisation in patients with chronic liver disease and liver transplantation recipients
40. X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis
41. Established and novel therapeutic options for autoimmune hepatitis
42. A Very Short Course of HBIg+NA Followed by Entecavir or Tenofovir Monotherapy Prevents HBV Recurrence in Low-Risk Liver Transplant Recipients
43. Type of calcineurin inhibitor and long-term outcomes following liver transplantation in patients with primary biliary cholangitis – an ELTR study
44. Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score
45. Approach to the patient with acute severe autoimmune hepatitis
46. Features and outcome of AIH patients without elevation of IgG
47. Rapid Response to Treatment of Autoimmune Hepatitis Associated With Remission at 6 and 12 Months
48. Seamless Management of Juvenile Autoimmune Liver Disease: Long-Term Medical and Social Outcome
49. Optimizing thiopurine therapy in autoimmune hepatitis: A multicenter study on monitoring metabolite profiles and co-therapy with allopurinol.
50. Autoimmune hepatitis and overlap syndrome
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.